08 July 2022
Researchers at Tomsk-based SibMed University (Siberian State Medical University) have developed new hybrid artificial intelligence (AI) technology to control multiple cyber-physical systems across medical disciplines.
At the core of the development are AI-driven systems to support physicians’ decision-making process which are based on data and on knowledge.
As modern computing and communication devices are getting increasingly compact and affordable, the creation of an array of sensor- and actuator-enabled cyber-physical systems is no longer a future plan. Sensors and other slave gadgets help collect tons of data on processes that take place in physical and biological objects.
What the SibMed team focused on was the development of decision-making support systems for doctors which could operate where datasets available are very limited and where both data and empirical and theoretical knowledge are required to do the job.
“Most AI systems for medical purposes serve the disciplines with huge amounts of information collected, such as X-ray diagnostics images, text data in electronic medical records, etc. Unfortunately, such systems cover but a fraction of what medicine requires to meet its needs,” said Ivan Tolmachov of SibMed’s Bionic Digital Platforms program.
The developers are currently using the new AI solution to assess biomechanical movement parameters in locomotor disability rehab cases and to optimize premature babies’ nutrition profile with unremitting blood sugar level monitoring.
With the technology, a broad range of diagnostic and therapeutic equipment could be coalesced in a single automatically controlled platform to capture and follow all processes that occur in the human body in real time.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024